Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1649

Clinical Application of Transcatheter Arterial Chemoembolization Combined with Synchronous C-arm Cone-Beam CT Guided Radiofrequency Ablation in treatment of Large Hepatocellular Carcinoma  

Wang, Zhi-Jun (Department of Interventional Radiology, PLA General Hospital)
Wang, Mao-Qiang (Department of Interventional Radiology, PLA General Hospital)
Duan, Feng (Department of Interventional Radiology, PLA General Hospital)
Song, Peng (Department of Interventional Radiology, PLA General Hospital)
Liu, Feng-Yong (Department of Interventional Radiology, PLA General Hospital)
Wang, Yan (Department of Interventional Radiology, PLA General Hospital)
Yan, Jie-Yu (Department of Interventional Radiology, PLA General Hospital)
Li, Kai (Department of Interventional Radiology, PLA General Hospital)
Yuan, Kai (Department of Interventional Radiology, PLA General Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1649-1654 More about this Journal
Abstract
Objective: This work aimed to evaluate the safety and clinical efficacy of transcatheter arterial chemoembolization (TACE) combined with c-arm cone-beam CT guided synchronous radiofrequency ablation (RFA) in treatment of large hepatocellular carcinoma (HCC). Methods: 21 patients with large HCC were studied from January 2010 to March 2012. TACE combined with synchronous C-arm cone-beam CT guided RFA were performed on a total of 25 lesions. Conventional imaging examination (CEUS, enhanced CT or MRI) and AFP detection were regularly conducted to evaluate the technical success rate of combined treatment, complications, treatment response, time without disease recurrence and survival rate. Results: The technical success rate of combined treatment was 100%, without any significant complication. After 1 month, there were 19 cases with complete response and 2 cases with partial response, with an complete response rate of 90.4% (19/21) and a clinical effective rate of 100% (21/21). The complete response rates of single nodular lesions (100%, 17/17) was significantly higher than that of multiple nodular lesions (50%, 2/4) (P<0. 05). During 2 to 28 months of follow-up, in 19 cases with complete response, the average time without disease recurrence was $10.8{\pm}6$ months. The total survival rates of 6, 12 and 18 months in 21 patients were 100%, respectively. Conclusion: TACE combined with synchronous C-arm CT guided RFA is safe and effective for treatment of large HCC. The treatment efficacy for single nodular lesion is better than that for multiple nodular lesions.
Keywords
Large HCC; chemoembolization; radiofrequency ablation; C-arm cone-beam CT; synchronous;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 35, 421-30.   DOI   ScienceOn
2 Fan WZ, Yang JY, Lü MD, et al (2011). Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors. Zhonghua Yi Xue Za Zhi, 91, 2190-4.
3 Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55.   DOI   ScienceOn
4 Gadaleta C, Catino A, Ranieri G, et al (2009). Single-step therapy -- feasibility and safety of simultaneous transarterial chemoembolization and radiofrequency ablation for hepatic malignancies. In Vivo, 23, 813-20.
5 Georgiades CS, Hong K, Geschwind JF, et al (2008). Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J, 14, 117-22.   DOI   ScienceOn
6 Head HW, Dodd GD 3rd, Bao A, et al (2010). Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology, 255, 405-14.   DOI   ScienceOn
7 Kang SG, Yoon CJ, Jeong SH, et al (2009). Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol, 20, 1570-7.   DOI   ScienceOn
8 Kim MH, Choi MS, Choi YS, et al (2006). Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma. Korean J Hepatol, 12, 55-64.   과학기술학회마을
9 Lee MW, Kim YJ, Park SW, et al (2009). Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. Br J Radiol, 82, 908-15.   DOI   ScienceOn
10 Lee MW, Kim YJ, Park SW, et al (2011). Biplane fluoroscopyguided radiofrequency ablation combined with chemoembolisation for hepatocellular carcinoma: initial experience. Br J Radiol, 84, 691-7.   DOI   ScienceOn
11 Marín-Hargreaves G, Azoulay D, Bismuth H (2003). Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol, 47, 13-27.   DOI   ScienceOn
12 Miyayama S, Yamashiro M, Okuda M, et al (2010). Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol, 21, 1226-34.   DOI   ScienceOn
13 Dhanasekaran R, Kooby DA, Staley CA, et al (2010). Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol, 101, 476-80.
14 Shimada K, Sakamoto Y, Esaki M, et al (2008). Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbecks Arch Surg, 393, 521-6.   DOI   ScienceOn
15 Shiraishi R, Yamasaki T, Saeki I, et al (2008). Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol, 31, 311-6.   DOI   ScienceOn
16 Takaki H, Yamakado K, Nakatsuka A, et al (2007). Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol, 18, 856-61.   DOI   ScienceOn
17 Yamakado K, Nakatsuka A, Ohmori S, et al (2002). Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol, 13, 1225-32.   DOI   ScienceOn
18 Takaki H, Yamakado K, Uraki J, et al (2009). Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol, 20, 217-24.   DOI   ScienceOn
19 Veltri A, Moretto P, Doriguzzi A, et al (2006). Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 16, 661-9.   DOI
20 Wang W, Shi J, Xie WF (2010). Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int, 30, 741-9.   DOI   ScienceOn
21 Yamakado K, Nakatsuka A, Takaki H, et al (2010). Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR Am J Roentgenol, 194, 530-5.   DOI   ScienceOn
22 Zangos S, Eichler K, Balzer JO, et al (2007). Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol, 17, 553-63.   DOI